These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8883711)
41. High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor. Meyers MO; Anthony LB; McCarthy KE; Drouant G; Maloney TJ; Espanan GD; Woltering EA South Med J; 2000 Aug; 93(8):809-11. PubMed ID: 10963516 [TBL] [Abstract][Full Text] [Related]
42. In situ radiotherapy with 111In-pentetreotide: initial observations and future directions. McCarthy KE; Woltering EA; Espenan GD; Cronin M; Maloney TJ; Anthony LB Cancer J Sci Am; 1998; 4(2):94-102. PubMed ID: 9532411 [TBL] [Abstract][Full Text] [Related]
43. Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma. Friedberg JW; Van den Abbeele AD; Kehoe K; Singer S; Fletcher CD; Demetri GD Cancer; 1999 Oct; 86(8):1621-7. PubMed ID: 10526294 [TBL] [Abstract][Full Text] [Related]
44. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma]. Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059 [TBL] [Abstract][Full Text] [Related]
45. Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. Lebtahi R; Le Cloirec J; Houzard C; Daou D; Sobhani I; Sassolas G; Mignon M; Bourguet P; Le Guludec D J Nucl Med; 2002 Jul; 43(7):889-95. PubMed ID: 12097458 [TBL] [Abstract][Full Text] [Related]
46. Imaging of non-small-cell lung cancer with indium-111 pentetreotide. Lau SK; Johnson DS; Coel MN Clin Nucl Med; 2000 Jan; 25(1):24-8. PubMed ID: 10634526 [TBL] [Abstract][Full Text] [Related]
47. [Receptor scintigraphy using 111In-pentetreotide in endocrine gastroenteropancreatic tumors]. Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Benning R; Neuhaus C; Lenze H; Trautmann ME; Arnold R Nuklearmedizin; 1993 Dec; 32(6):299-305. PubMed ID: 7905200 [TBL] [Abstract][Full Text] [Related]
48. 111In-pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging. Schillaci O; Massa R; Scopinaro F J Nucl Med; 2000 Mar; 41(3):459-62. PubMed ID: 10716319 [TBL] [Abstract][Full Text] [Related]
49. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Hofmann M; Maecke H; Börner R; Weckesser E; Schöffski P; Oei L; Schumacher J; Henze M; Heppeler A; Meyer J; Knapp H Eur J Nucl Med; 2001 Dec; 28(12):1751-7. PubMed ID: 11734911 [TBL] [Abstract][Full Text] [Related]
50. Changing approach to gastroenteropancreatic tumours. Case report of a gastrinoma metastasis localized by somatostatin-receptor scintigraphy. Fries W; Moschino P; Chierichetti F; Carniato S; Martines D; Martin A; Cecchetto A; Ricciardi G; Stracca-Pansa V; Naccarato R; Corsini A Ital J Gastroenterol; 1996 May; 28(4):220-4. PubMed ID: 8842838 [TBL] [Abstract][Full Text] [Related]